Insider · CIK 0001735944

Reshma Kewalramani

ceopresidentofficerdirector

Files at VRTX (VERTEX PHARMACEUTICALS INC / MA). First filing Nov 12, 2024, latest Aug 7, 2025.

Track record

Not enough history

Fewer than three past buys with six months of prices.

Median 6-month excess

after past buys, n = 0

Hit rate

past buys that beat the index over 6 months

Open-market trades

1 / 1

$3.9M bought, $7.8M sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

VRTX: VERTEX PHARMACEUTICALS INC / MA

VRTXOct 9, 2026 · close 510.08

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

Score	Company	Value	Holdings	Price context	Filed
75Notable	VRTXbuy 2 VERTEX PHARMACEUTICALS INC / MA	$3.9M 10,000 shares	+9%	+3% from low-25% from high	Aug 7, 2025
50Moderate	VRTXsell 310b5-1 VERTEX PHARMACEUTICALS INC / MA	$7.8M 15,198 shares	-17%	+15% from low0% from high	Nov 12, 2024

Transactions

Every row this insider has filed, newest first.

Date	Company	Transaction	Shares	Price	Value	Holdings after	Filed
Aug 6, 2025	VRTX VERTEX PHARMACEUTICALS INC / MA	POpen-market purchase Common Stock	+4,290	$389.08	$1.7M	110,258	Aug 7, 2025
Aug 6, 2025	VRTX VERTEX PHARMACEUTICALS INC / MA	POpen-market purchase Common Stock	+5,710	$389.95	$2.2M	115,968	Aug 7, 2025
Feb 26, 2025	VRTX VERTEX PHARMACEUTICALS INC / MA	FTax withholding Common Stock	-14,079	$479.61	$6.8M	105,915	Feb 28, 2025
Feb 24, 2025	VRTX VERTEX PHARMACEUTICALS INC / MA	FTax withholding Common Stock	-9,386	$483.28	$4.5M	119,994	Feb 26, 2025
Feb 14, 2025	VRTX VERTEX PHARMACEUTICALS INC / MA	FTax withholding Common Stock	-6,553	$463.46	$3.0M	129,380	Feb 19, 2025
Feb 12, 2025	VRTX VERTEX PHARMACEUTICALS INC / MA	AGrant or award Common Stock	+19,015	$0.00	$0	135,933	Feb 14, 2025
Feb 10, 2025	VRTX VERTEX PHARMACEUTICALS INC / MA	FTax withholding Common Stock	-8,300	$467.98	$3.9M	116,918	Feb 12, 2025
Feb 4, 2025	VRTX VERTEX PHARMACEUTICALS INC / MA	AGrant or award Common Stock	+29,118	$0.00	$0	104,890	Feb 6, 2025
Feb 4, 2025	VRTX VERTEX PHARMACEUTICALS INC / MA	AGrant or award Common Stock	+20,328	$0.00	$0	125,218	Feb 6, 2025
Nov 8, 2024	VRTX VERTEX PHARMACEUTICALS INC / MA	SOpen-market sale Common Stock10b5-1	-15,198	$515.00	$7.8M	75,772	Nov 12, 2024

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.